查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424052

皮质类固醇市场、份额、规模、趋势、产业分析报告：按类型、给药途径、应用、地区、细分市场预测，2024-2032

Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球皮质类固醇市场规模预计将达到85.3亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

气喘、类风湿关节炎和皮肤病等慢性疾病的激增正在推动皮质类固醇市场的机会。 皮质类固醇由于其强大的抗发炎特性而在这些疾病的治疗中至关重要，并且在全世界范围内需求量很大。 在生活方式因素的推动下，对有效抗发炎解决方案的需求已将皮质类固醇置于最前线。 製药创新至关重要，它使公司能够开发针对特定慢性疾病的配方，并满足皮质类固醇市场对标靶治疗解决方案日益增长的需求。

皮质类固醇市场正在利用生物製剂和联合疗法潜在整合所带来的机会。 具有标靶机制的生物製剂可以与皮质类固醇的广泛抗发炎作用产生协同作用，旨在改善治疗结果并减少副作用。 多样化的治疗方式对于自体免疫和发炎性疾病的动态变化至关重要。 作用于特定途径的生物製剂为皮质类固醇治疗增添了个人化维度。 这个策略组合将推动新配方和治疗方案的开发，为管理复杂的疾病状况提供更有效和量身定制的解决方案，并推动皮质类固醇市场的逐步变革，有望提高治疗效果。

远距医疗和电子医疗在塑造皮质类固醇市场方面变得越来越重要，带来了新的机会。 医疗保健的数位化使远距咨询成为可能，并方便了获得皮质类固醇处方。 这些平台使医疗保健提供者能够监测患者并确保及时调整皮质类固醇治疗方案。

电子医疗解决方案简化了资讯流，并加强了患者对皮质类固醇使用和副作用的教育。 这种数位整合不仅会提高患者的依从性，还会扩大皮质类固醇治疗的采用，特别是有利于服务不足的人。 透过利用远距医疗提供的便利性和效率，皮质类固醇市场培育了以患者为中心的方法，为创新、数据驱动的见解和增强医疗保健的可近性铺平了道路。

肾上腺皮质类固醇市场报告亮点

到 2023 年，糖皮质激素领域因其多功能性、慢性病管理和治疗进展而占据了重要的市场份额。

2023年，由于抑制全身吸收、局部治疗以及与其他治疗的兼容性，外用细分市场占据了很大的市场份额。

2023 年，皮肤过敏领域因其抗炎特性、快速症状缓解和广泛的应用而占据了主要收入份额。

2023 年，北美地区凭藉其成熟的公司、监管环境、持续的技术进步和研发，在全球市场占据主导地位。

全球市场参与者包括AbbVie Inc.、AstraZeneca plc、Bayer AG、Cipla Limited、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Sanofi S.A.。因此，市场竞争非常激烈。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球皮质类固醇市场洞察

  • 皮质类固醇市场 - 应用概况
  • 皮质类固醇市场动态
    • 促进因素和机会
      • 药物配方的进步预计将刺激对该产品的需求
      • 人口老化的加剧预计将推动市场成长
    • 抑制因素和挑战
      • 副作用和副作用可能会阻碍市场成长
  • PESTEL 分析
  • 皮质类固醇市场应用趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球皮质类固醇市场，依给药途径划分

  • 主要发现
  • 简介
  • 吸入
  • 局部
  • 注射
  • 口头

第 6 章全球皮质类固醇市场，依类型

  • 主要发现
  • 简介
  • 盐皮质激素
  • 糖皮质激素

第 7 章全球皮质类固醇市场，依应用划分

  • 主要发现
  • 简介
  • 皮肤过敏
  • 胃肠病学
  • 内分泌科
  • 急性呼吸道疾病
  • 风湿病适应症
  • 其他

第 8 章全球皮质类固醇市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年皮质类固醇市场评估（按地区）
  • 皮质类固醇市场 - 北美
    • 北美：皮质类固醇市场，依给药途径划分，2019-2032 年
    • 北美：皮质类固醇市场，依应用分类，2019-2032 年
    • 北美：皮质类固醇市场，依类型，2019-2032 年
    • 皮质类固醇市场 - 美国
    • 皮质类固醇市场 - 加拿大
  • 皮质类固醇市场 - 欧洲
    • 欧洲：皮质类固醇市场，依给药途径划分，2019-2032 年
    • 欧洲：皮质类固醇市场，按应用划分，2019-2032 年
    • 欧洲：皮质类固醇市场，按类型，2019-2032 年
    • 皮质类固醇市场 - 英国
    • 皮质类固醇市场 - 法国
    • 皮质类固醇市场 - 德国
    • 皮质类固醇市场 - 义大利
    • 皮质类固醇市场 - 西班牙
    • 皮质类固醇市场 - 荷兰
    • 皮质类固醇市场 - 俄罗斯
  • 皮质类固醇市场 - 亚太地区
    • 亚太地区：皮质类固醇市场，依给药途径划分，2019-2032 年
    • 亚太地区：皮质类固醇市场，依应用划分，2019-2032 年
    • 亚太地区：皮质类固醇市场，依类型，2019-2032 年
    • 皮质类固醇市场 - 中国
    • 皮质类固醇市场 - 印度
    • 皮质类固醇市场 - 马来西亚
    • 皮质类固醇市场 - 日本
    • 皮质类固醇市场 - 印尼
    • 皮质类固醇市场 - 韩国
  • 皮质类固醇市场 - 中东和非洲
    • 中东与非洲：皮质类固醇市场，依给药途径划分，2019-2032 年
    • 中东和非洲：皮质类固醇市场，按应用划分，2019-2032 年
    • 中东和非洲：皮质类固醇市场，按类型，2019-2032 年
    • 皮质类固醇市场－沙乌地阿拉伯
    • 皮质类固醇市场－阿拉伯联合大公国
    • 皮质类固醇市场 - 以色列
    • 皮质类固醇市场 - 南非
  • 皮质类固醇市场 - 拉丁美洲
    • 拉丁美洲：皮质类固醇市场，依给药途径划分，2019-2032 年
    • 拉丁美洲：皮质类固醇市场，按应用划分，2019-2032 年
    • 拉丁美洲：皮质类固醇市场，依类型，2019-2032 年
    • 皮质类固醇市场 - 墨西哥
    • 皮质类固醇市场 - 巴西
    • 皮质类固醇市场 - 阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
Product Code: PM4413

The global Corticosteroids market size is expected to reach USD 8.53 billion by 2032, according to a new study by Polaris Market Research. The report "Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surging prevalence of chronic diseases such as asthma, rheumatoid arthritis, and dermatological disorders propels opportunities in the corticosteroids market. Vital for managing these conditions due to their potent anti-inflammatory properties, corticosteroids witness rising demand globally. Fueled by lifestyle factors, the demand for effective anti-inflammatory solutions positions corticosteroids at the forefront. Pharmaceutical innovation becomes crucial, presenting companies with the prospect of developing tailored formulations for specific chronic diseases, meeting the growing need for targeted therapeutic solutions in the corticosteroids market.

The corticosteroids market is capitalizing on opportunities presented by the potential integration of biologics and combination therapies. Biologics, with targeted mechanisms, synergize with the broad anti-inflammatory actions of corticosteroids, aiming for enhanced therapeutic outcomes and reduced side effects. In the dynamic landscape of autoimmune and inflammatory disorders, diversified treatment modalities are crucial. Biologics, addressing specific pathways, add a personalized dimension to corticosteroid treatments. This strategic combination fosters the development of novel formulations and treatment regimens, offering more effective and tailored solutions for managing complex conditions, marking a progressive shift in the corticosteroids market and promising improved therapeutic efficacy.

Telemedicine and E-Health are increasingly pivotal in shaping the corticosteroids market, opening novel opportunities. The digital transformation in healthcare allows for remote consultations, facilitating easier access to corticosteroid prescriptions. These platforms empower healthcare providers to monitor patients, ensuring timely adjustments to corticosteroid regimens.

E-Health solutions streamline information flow, enhancing patient education on corticosteroid usage and side effects. This digital integration not only boosts patient adherence but also broadens the reach of corticosteroid therapies, particularly benefiting underserved populations. The corticosteroids market capitalizes on the convenience and efficiency introduced by telemedicine, fostering a patient-centric approach and creating avenues for innovation, data-driven insights, and enhanced healthcare accessibility.

Corticosteroids Market Report Highlights

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

Polaris Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Mineralocorticoids
  • Glucocorticoids

Corticosteroids, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inhaled
  • Topical
  • Injectable
  • Oral

Corticosteroids, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Skin Allergies
  • Gastroenterology
  • Endocrinology
  • Acute Respiratory Diseases
  • Rheumatology Indications
  • Others

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Corticosteroids Market Insights

  • 4.1. Corticosteroids Market - Application Snapshot
  • 4.2. Corticosteroids Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in drug formulations are projected to spur the product demand
      • 4.2.1.2. Rising aging population is expected to drive market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse reactions and side effects are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Corticosteroids Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Corticosteroids Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • 5.3. Inhaled
    • 5.3.1. Global Corticosteroids Market, by Inhaled, by Region, 2019-2032 (USD Billion)
  • 5.4. Topical
    • 5.4.1. Global Corticosteroids Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 5.5. Injectable
    • 5.5.1. Global Corticosteroids Market, by Injectable, by Region, 2019-2032 (USD Billion)
  • 5.6. Oral
    • 5.6.1. Global Corticosteroids Market, by Oral, by Region, 2019-2032 (USD Billion)

6. Global Corticosteroids Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Mineralocorticoids
    • 6.3.1. Global Corticosteroids Market, by Mineralocorticoids, by Region, 2019-2032 (USD Billion)
  • 6.4. Glucocorticoids
    • 6.4.1. Global Corticosteroids Market, by Glucocorticoids, by Region, 2019-2032 (USD Billion)

7. Global Corticosteroids Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Skin Allergies
    • 7.3.1. Global Corticosteroids Market, by Skin Allergies, By Region, 2019-2032 (USD Billion)
  • 7.4. Gastroenterology
    • 7.4.1. Global Corticosteroids Market, by Gastroenterology, By Region, 2019-2032 (USD Billion)
  • 7.5. Endocrinology
    • 7.5.1. Global Corticosteroids Market, by Endocrinology, By Region, 2019-2032 (USD Billion)
  • 7.6. Acute Respiratory Diseases
    • 7.6.1. Global Corticosteroids Market, by Acute Respiratory Diseases, By Region, 2019-2032 (USD Billion)
  • 7.7. Rheumatology Indications
    • 7.7.1. Global Corticosteroids Market, by Rheumatology Indications, By Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Corticosteroids Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Corticosteroids Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Corticosteroids Market - North America
    • 8.3.1. North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.2. North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Corticosteroids Market - U.S.
      • 8.3.4.1. U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Corticosteroids Market - Canada
      • 8.3.5.1. Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Corticosteroids Market - Europe
    • 8.4.1. Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Corticosteroids Market - UK
      • 8.4.4.1. UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Corticosteroids Market - France
      • 8.4.5.1. France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Corticosteroids Market - Germany
      • 8.4.6.1. Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Corticosteroids Market - Italy
      • 8.4.7.1. Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Corticosteroids Market - Spain
      • 8.4.8.1. Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Corticosteroids Market - Netherlands
      • 8.4.9.1. Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Corticosteroids Market - Russia
      • 8.4.10.1. Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Corticosteroids Market - Asia Pacific
    • 8.5.1. Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Corticosteroids Market - China
      • 8.5.4.1. China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Corticosteroids Market - India
      • 8.5.5.1. India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Corticosteroids Market - Malaysia
      • 8.5.6.1. Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Corticosteroids Market - Japan
      • 8.5.7.1. Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Corticosteroids Market - Indonesia
      • 8.5.8.1. Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Corticosteroids Market - South Korea
      • 8.5.9.1. South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Corticosteroids Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Corticosteroids Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Corticosteroids Market - UAE
      • 8.6.5.1. UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Corticosteroids Market - Israel
      • 8.6.6.1. Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Corticosteroids Market - South Africa
      • 8.6.7.1. South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Corticosteroids Market - Latin America
    • 8.7.1. Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Corticosteroids Market - Mexico
      • 8.7.4.1. Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Corticosteroids Market - Brazil
      • 8.7.5.1. Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Corticosteroids Market - Argentina
      • 8.7.6.1. Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Astellas Pharma Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AstraZeneca plc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bausch Health Companies Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bayer AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cipla Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Eli Lilly and Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. F. Hoffmann-La Roche Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. GlaxoSmithKline plc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Johnson & Johnson
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Lupin Limited
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Merck & Co., Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis International AG
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Pfizer Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sanofi S.A.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 2 Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 6 North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 15 Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 21 France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 27 Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 30 Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 42 China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 45 India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 51 Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 57 South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 66 UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 75 Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 81 Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Corticosteroids Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Corticosteroids Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Corticosteroids Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Corticosteroids Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Corticosteroids Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Corticosteroids Market